Dubai Final-v20.indd - World Allergy Organization

More documents

Recommendations

Info

POstEr AUtHOr inDEX WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE Asthma and Co-morbid Conditions: Expanding the Practice of <strong>Allergy</strong> for Optimal Patient Care author Poster # Session author Poster # Session author Poster # Session Pourpak, Z 1113 PO 1-1 Prakash rao, m 1207 PO 1-2 Pratt, C 1112 PO 1-1 Price, D 1210 PO 1-2 Price, D 1211 PO 1-2 Price, D 1212 PO 1-2 Price, D 1319 PO 1-3 Price, D 1213 PO 1-2 Psarros, P 2302 PO 2-3 Psarros, P 2303 PO 2-3 r, D 1221 PO 1-2 r, g 1411 PO 1-4 r, g 1221 PO 1-2 r, iii, m 1411 PO 1-4 rafique, m 1303 PO 1-3 rafique, m 3100 PO 3-1 raj, s 1301 PO 1-3 ramirez, r 2216 PO 2-2 randa, O 1215 PO 1-2 reddy, rrK 3109 PO 3-1 rengganis, i 1115 PO 1-1 restrepo, m 2216 PO 2-2 restrepo, m 2307 PO 2-3 restrepo, m 2217 PO 2-2 restrepo, m 2110 PO 2-1 rezaei, n 1402 PO 1-4 rha, YH 3316 PO 3-3 ribeiro, m 1306 PO 1-3 riedl , m 2308 PO 2-3 riedl , m 2309 PO 2-3 riedl , m 2311 PO 2-3 riedl , m 2312 PO 2-3 rodríguez- Domínguez, sr., B 2306 PO 2-3 roedland, EA 1313 PO 1-3 roh, s 1107 PO 1-1 rojek, B 1400 PO 1-4 romano, A 2212 PO 2-2 roongrotwattanasiri, K 1412 PO 1-4 rosifah, D 2109 PO 2-1 ruiz Hornillos, F 2306 PO 2-3 rumi, g 2212 PO 2-2 ryan, D 1210 PO 1-2 s P, PK 1307 PO 1-3 s P, PK 1108 PO 1-1 sA.madani, A 2300 PO 2-3 saad, s 2213 PO 2-2 saadeh, C 1109 PO 1-1 sabry, EY 1300 PO 1-3 saeki, t 2207 PO 2-2 sah, s 1401 PO 1-4 saha, gK 1103 PO 1-1 ahin, F 1214 PO 1-2 sahraoui, F 3313 PO 3-3 saito, H 3102 PO 3-1 salekmoghadam, A 1402 PO 1-4 salvatici, E 2209 PO 2-2 sam, rA 3109 PO 3-1 sami, As 1405 PO 1-4 sami, As 1406 PO 1-4 sami, As 3305 PO 3-3 samoliñski, B 1400 PO 1-4 sanchez, J 2307 PO 2-3 sanchez, J 2217 PO 2-2 sanchez, J 2110 PO 2-1 sapartini, g 2109 PO 2-1 sapartini, g 1117 PO 1-1 sapartini, g 1327 PO 1-3 saptaputra, W 1117 PO 1-1 saptaputra, W 3319 PO 3-3 saptaputra, W 1327 PO 1-3 saranac, lm 3315 PO 3-3 sarno, g 1309 PO 1-3 sarno, g 1312 PO 1-3 sawas, K 3200 PO 3-2 sazdovski, A 3320 PO 3-3 schiavino, D 1119 PO 1-1 schnitker, J 3212 PO 3-2 seçik, F 1214 PO 1-2 seckova, l 3320 PO 3-3 sekiya, K 1305 PO 1-3 selimovic, A 3302 PO 3-3 selimovic, A 3303 PO 3-3 senevirathne, K 1328 PO 1-3 sepiashvili, ri 1311 PO 1-3 sepiashvili, ri 1111 PO 1-1 setiabudiawan, B 2109 PO 2-1 setiabudiawan, B 1117 PO 1-1 setiabudiawan, B 1327 PO 1-3 shah, r 1301 PO 1-3 shah, s 1209 PO 1-2 shamssain, m 1317 PO 1-3 shamssain, m 1318 PO 1-3 sharef, sW 1116 PO 1-1 shehab, A 2213 PO 2-2 sheikh, A 2201 PO 2-2 shin, KC 1114 PO 1-1 shin, s 3312 PO 3-3 shoda, t 3306 PO 3-3 siddiqui, W 1106 PO 1-1 silva, nA 1120 PO 1-1 silvi, P 1309 PO 1-3 simoes, EA 3319 PO 3-3 simoes, EA 1327 PO 1-3 simone, P 3204 PO 3-2 simone, P 3205 PO 3-2 simoni, m 1309 PO 1-3 sims, EJ 1211 PO 1-2 sinaniotis, A 2302 PO 2-3 sinaniotis, A 2303 PO 2-3 siribaddana, A 1328 PO 1-3 slavyanskaya, tA 1311 PO 1-3 sliem, H 1219 PO 1-2 sofia, m 3112 PO 3-1 sofia, m 2215 PO 2-2 soto, g 2206 PO 2-2 soto Vargas, g 2205 PO 2-2 sporisevic, l 3302 PO 3-3 sporisevic, l 3303 PO 3-3 sudarwati, s 3319 PO 3-3 sulaiman, n 1303 PO 1-3 suljevic, i 3302 PO 3-3 suljevic, i 3303 PO 3-3 sus-Carrizosa, s 2216 PO 2-2 suwardi, AU 3319 PO 3-3 syrigos, Kn 2202 PO 2-2 syrigou, E 2202 PO 2-2 syrigou, E 2302 PO 2-3 syrigou, E 2303 PO 2-3 szalai, C 3110 PO 3-1 takaku, Y 1206 PO 1-2 takeshi, n 3308 PO 3-3 takzare, A 3323 PO 3-3 takzare, n 3323 PO 3-3 takzaree, A 3322 PO 3-3 takzaree, n 3322 PO 3-3 tamayo, l 2307 PO 2-3 taniguchi, m 1305 PO 1-3 tanimoto, H 1305 PO 1-3 thomas, m 1210 PO 1-2 tillotson, g 2308 PO 2-3 tillotson, g 2309 PO 2-3 tillotson, g 2310 PO 2-3 tillotson, g 2311 PO 2-3 tillotson, g 2312 PO 2-3 tn, B 1325 PO 1-3 tomikawa, m 3309 PO 3-3 torrecillas, m 2205 PO 2-2 torrecillas, sr., m 2206 PO 2-2 tort, m 1408 PO 1-4 toshiaki, s 3308 PO 3-3 tsai, CJ 3104 PO 3-1 tsuburai, t 1305 PO 1-3 tsumura, Y 3306 PO 3-3 Uknis, m 2308 PO 2-3 Uknis, m 2309 PO 2-3 Uknis, m 2310 PO 2-3 Uknis, m 2311 PO 2-3 Uknis, m 2312 PO 2-3 Ungvari, i 3110 PO 3-1 Vafa, A 1208 PO 1-2 Valluzzi, rl 2212 PO 2-2 Varasteh, A 1402 PO 1-4 Vatanchian, m 1113 PO 1-1 Vazquez tello, A 1323 PO 1-3 Vazquez tello, A 2108 PO 2-1 Vegh, A 2309 PO 2-3 Vermani, m 1106 PO 1-1 Viegi, g 1309 PO 1-3 Viegi, g 1312 PO 1-3 Vijayan, V 1106 PO 1-1 Villano, s 2308 PO 2-3 Villano, s 2309 PO 2-3 Villano, s 2310 PO 2-3 Villano, s 2311 PO 2-3 Villano, s 2312 PO 2-3 Viola, m 2212 PO 2-2 Virag, V 3110 PO 3-1 Virchow, C 1319 PO 1-3 Vranic, B 3303 PO 3-3 Wah, WZ 2100 PO 2-1 Wang, DY 1407 PO 1-4 Wanigasekara, PC 1328 PO 1-3 Wegienka, g 1302 PO 1-3 White, m 2308 PO 2-3 White, m 2309 PO 2-3 Wilson, ms 3107 PO 3-1 Wm, Wm 1401 PO 1-4 Wolf, H 3212 PO 3-2 Wong, Hg 2200 PO 2-2 Wuestenberg, Eg 3212 PO 3-2 www.worldallergy.org 168 FinAl PrOgrAm
POstEr AUtHOr inDEX WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE Asthma and Co-morbid Conditions: Expanding the Practice of <strong>Allergy</strong> for Optimal Patient Care author Poster # Session author Poster # Session author Poster # Session Wulandari, DA 3319 PO 3-3 Y, nK 1401 PO 1-4 Yıldırım, E 1214 PO 1-2 Yıldız, P 1214 PO 1-2 Yagi, t 1412 PO 1-4 Yamaguchi, t 1206 PO 1-2 Yamamoto, K 3306 PO 3-3 Yavas, s 2104 PO 2-1 Ye, Y 1102 PO 1-1 Ye, Y 1104 PO 1-1 Ye, Y 3312 PO 3-3 Yong, sJ 1114 PO 1-1 Yoon, HJ 1314 PO 1-3 Yoon, HJ 1218 PO 1-2 Yoon, J 3113 PO 3-1 Yoshida, K 3306 PO 3-3 Yun, is 1110 PO 1-1 Yutaka, K 3308 PO 3-3 Zaharov, t 2304 PO 2-3 Zakharyan, A 3307 PO 3-3 Zhang, H 2105 PO 2-1 Zhu, X 2105 PO 2-1 Zidoune, mn 2214 PO 2-2 Zivanovic, ss 3315 PO 3-3 Zoratti, E 1302 PO 1-3 Zuraw, B 2308 PO 2-3 Zuraw, B 2309 PO 2-3 Zuvadelli, J 2209 PO 2-2 www.worldallergy.org 169 FinAl PrOgrAm
Page 1 and 2:
Final Program 5-8 December 2010 •
Page 3 and 4:
CO COImportant Dates 30 June 2011 E
Page 5 and 6:
WAO IntErnAtIOnAl ScIEntIfIc cOnfEr
Page 7 and 8:
ABOUt WAO the World Allergy Organiz
Page 9:
WAO mEmBEr sOCiEtiEs Albanian socie
Page 12 and 13:
gEnErAl inFOrmAtiOn, A-Z BAnKs/Atm
Page 14 and 15:
ONBREZ ® BREEZHALER ® Important n
Page 16 and 17:
COnFErEnCE inFOrmAtiOn, A-Z DisClAi
Page 18 and 19:
COnFErEnCE inFOrmAtiOn, A-Z sPEAKEr
Page 20 and 21:
Helping to control asthma throughou
Page 22 and 23:
OPtiOnAl tOUrs CitY OF COntrAsts -
Page 24 and 25:
EXHiBitiOn FlOOrPlAn sHEiKH rAsHiD
Page 26 and 27:
EXHiBitOr DirECtOrY EaaCi - Europea
Page 28:
EXHiBitOr DirECtOrY omron Healthcar
Page 32 and 33:
WAO IntErnAtIOnAl ScIEntIfIc cOnfEr
Page 34 and 35:
PrOgrAm-At-A-glAnCE registration Ou
Page 36 and 37:
sUnDAY, 5 DECEmBEr 2010 WAO IntErnA
Page 38 and 39:
sUnDAY, 5 DECEmBEr 2010 WAO IntErnA
Page 40 and 41:
mOnDAY, 6 DECEmBEr 2010 WAO IntErnA
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
tUEsDAY, 7 DECEmBEr 2010 WAO IntErn
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
WEDnEsDAY, 8 DECEmBEr 2010 WAO IntE
Page 54 and 55:
WEDnEsDAY, 8 DECEmBEr 2010 WAO IntE
Page 56 and 57:
POstErs POstErs WAO IntErnAtIOnAl S
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78:
Page 81 and 82:
ABstrACts results: the prevalence o
Page 83 and 84:
ABstrACts effective diagnosis and e
Page 85 and 86:
ABstrACts mWCnts on OVA-asthma mode
Page 87 and 88:
ABstrACts allergy in human. A Burka
Page 89 and 90:
ABstrACts Patients with all negativ
Page 91 and 92:
ABstrACts both gender, suggesting a
Page 93 and 94:
ABstrACts 1208 THE rolE oF inTErlEU
Page 95 and 96:
ABstrACts of oral steroids in last
Page 97 and 98:
ABstrACts 1215 aSTHma ComPliCaTion
Page 99 and 100:
ABstrACts to allergens, lower sever
Page 101 and 102:
ABstrACts 1301 non-EoSinoPHiliC aST
Page 103 and 104:
ABstrACts participated in this stud
Page 105 and 106:
ABstrACts for attacks of shortness
Page 107 and 108:
ABstrACts blood CD4+ t cells expres
Page 109 and 110:
ABstrACts Conclusion Air pollution
Page 111 and 112:
ABstrACts 1322 EPiTHElial CEll DEri
Page 113 and 114:
ABstrACts 1326 analYSiS oF gEnE EXP
Page 115 and 116:
ABstrACts rhinitis patients in Hosp
Page 117 and 118:
ABstrACts selected adults from the
Page 119 and 120: ABstrACts nasal Olopatadine led to
Page 121 and 122: ABstrACts therapy. However, patient
Page 123 and 124: ABstrACts that when Ds within the s
Page 125 and 126: ABstrACts result the patient was di
Page 127 and 128: ABstrACts 2203 FooD allErgY anD aTo
Page 129 and 130: ABstrACts 1.11+/- 0.81 for type i a
Page 131 and 132: ABstrACts 2212 aSSESSing PoTEnTial
Page 133 and 134: ABstrACts regular treatment with be
Page 135 and 136: ABstrACts 2301 EFFECT oF a SYnBioTi
Page 137 and 138: ABstrACts C3 (50 mg/dl; normal 90 -
Page 139 and 140: ABstrACts introduction : HAE is a g
Page 141 and 142: ABstrACts PoSTEr SESSion 3-1: immun
Page 143 and 144: ABstrACts smaller than 100 nm. Cell
Page 145 and 146: ABstrACts and dry weather city of A
Page 147 and 148: ABstrACts 3114 igg4 aS THE PrEDomin
Page 149 and 150: ABstrACts Conclusion: Our study dem
Page 151 and 152: ABstrACts abscesses are visible at
Page 153 and 154: ABstrACts allergen release (depot e
Page 155 and 156: ABstrACts COnClUsiOns: Empiric trea
Page 157 and 158: ABstrACts Conclusion:sPlAD and FPig
Page 159 and 160: ABstrACts autumn only in 13% of cas
Page 161 and 162: ABstrACts mEtHODs: ninety-six child
Page 163 and 164: ABstrACts 3321 aSSoCiaTion BETWEEn
Page 165 and 166: sPEAKEr AnD CHAirPErsOn inDEX last
Page 167 and 168: POstEr AUtHOr inDEX WAO IntErnAtIOn
Page 169: POstEr AUtHOr inDEX WAO IntErnAtIOn
Page 173 and 174: nOtEs WAO IntErnAtIOnAl ScIEntIfIc
Page 175 and 176: Q411-10 Allergic disease is a growi
Page 177: 2010 WAO IntErnAtIOnAl ScIEntIfIc c
show all

Dubai Final-v20.indd - World Allergy Organization

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?